Gufic Biosciences Limited (NSE:GUFICBIO)

India · Delayed Price · Currency is INR

285.00

-10.65 (-3.60%)

Feb 19, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical and Related Products	8.20B	8.07B	6.91B	7.79B	4.88B
Pharmaceutical and Related Products Growth	1.63%	16.80%	-11.36%	59.76%	28.74%
Total	8.20B	8.07B	6.91B	7.79B	4.88B
Total Growth	1.63%	16.80%	-11.36%	59.76%	28.74%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	6.54B	7.19B	5.84B	7.07B	4.28B
India Growth	-8.91%	23.09%	-17.44%	65.15%	31.21%
Africa	241.44M	98.75M	134.14M	90.89M	74.47M
Africa Growth	144.50%	-26.39%	47.58%	22.05%	12.02%
Asia	495.54M	363.02M	511.62M	281.23M	262.14M
Asia Growth	36.51%	-29.05%	81.92%	7.28%	-10.64%
Europe	617.81M	296.40M	294.23M	255.21M	199.64M
Europe Growth	108.44%	0.74%	15.29%	27.84%	61.33%
North America	97.45M	102.38M	116.19M	83.53M	48.62M
North America Growth	-4.81%	-11.88%	39.09%	71.81%	73.30%
Australia	6.25M	2.02M	5.36M	4.06M	3.59M
Australia Growth	209.10%	-62.26%	31.86%	12.99%	25.62%
South America	194.70M	18.89M	7.50M	6.24M	7.31M
South America Growth	930.99%	151.80%	20.12%	-14.57%	-33.63%
Total	8.20B	8.07B	6.91B	7.79B	4.88B
Total Growth	1.63%	16.80%	-11.36%	59.76%	28.74%

Source: S&P Global Market Intelligence.